Inspection classificationInspection ended September 15, 2026

FDA inspection of Department of Defense- Navy; US Naval Family Branch Clinic Iwakuni: NAI

No action indicated

FDA's record ↗

FDA classified an inspection of Department of Defense- Navy; US Naval Family Branch Clinic Iwakuni in Iwakuni, Japan as NAI (no action indicated). The inspection ended on September 15, 2026. Product type: Biologics.

On the record

Establishment
Department of Defense- Navy; US Naval Family Branch Clinic Iwakuni
Location
Iwakuni, Japan
Classification
NAI · No action indicated
Inspection ended
2026-09-15
Product type
Biologics
Fiscal year
FY2026
FDA establishment identifier (FEI)
3019948174
Source
FDA Data Dashboard ↗

The full record

An account shows the project areas inspected and whether citations were posted.

What an inspection classification is

After an inspection FDA classifies the outcome. NAI (no action indicated): no objectionable conditions were found, or none that justify further action. VAI (voluntary action indicated): objectionable conditions were found, but the agency is not prepared to take or recommend regulatory action. OAI (official action indicated): regulatory or administrative action is recommended.

More

Watch Department of Defense- Navy; US Naval Family Branch Clinic Iwakuni

A free account shows the last 7 days of every record. Pro adds a watchlist: one email when FDA acts on a company you name.

From FDA Data Dashboard; FDA posts a classification after its review, which can be months after the inspection ended. The record may have changed since it was read.

Approve Suite is not affiliated with FDA, or with Department of Defense- Navy; US Naval Family Branch Clinic Iwakuni.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.